We demonstrated that the knockdown of ITGB3 increased radiosensitization by promoting osteogenic differentiation and apoptosis through activation of the JNK/c-JUN/RUNX2 pathway in osteosarcoma. Here, RUNX2 is linked to osteosarcoma.